Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,210 | -24,590 | -18,866 | -11,650 | -4,215 |
| Depreciation Amortization | 37 | 211 | 342 | 63 | 15 |
| Accounts receivable | 300 | -300 | N/A | N/A | N/A |
| Other Working Capital | 259 | 1,718 | 656 | 281 | 307 |
| Other Operating Activity | 853 | 8,433 | 6,898 | 4,242 | 758 |
| Operating Cash Flow | $-4,761 | $-14,528 | $-10,970 | $-7,063 | $-3,135 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -174 | -170 | -170 | -35 |
| Investing Cash Flow | $N/A | $-174 | $-170 | $-170 | $-35 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -42 | -223 | -167 | -100 | -34 |
| Common Stock Issued | 0 | 17,647 | 7,214 | 4,786 | 58 |
| Financing Cash Flow | $-42 | $17,424 | $7,047 | $4,686 | $24 |
| Beginning Cash Position | 13,100 | 10,378 | 10,378 | 10,378 | 10,378 |
| End Cash Position | 8,297 | 13,100 | 6,285 | 7,832 | 7,231 |
| Net Cash Flow | $-4,803 | $2,722 | $-4,093 | $-2,547 | $-3,147 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,761 | -14,528 | -10,970 | -7,063 | -3,135 |
| Capital Expenditure | N/A | -174 | -170 | -170 | -35 |
| Free Cash Flow | -4,761 | -14,702 | -11,140 | -7,233 | -3,171 |